EUVIMEDEUVIMED entdecken
Crossref

Kinetin mediated mutant huntingtin phosphorylation restores multiple dysregulated pathways in a cell line model of Huntington’s disease

Rajubhai Dabhi, Ragi Mehta, Dhruvi Kakadiya, Ravi Vijayvargia

Human Molecular Genetics · 2025

DOI: 10.1093/hmg/ddaf052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Molecular Genetics, 2025. Verfasst von Rajubhai Dabhi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Neurobiology and Molecular Diagnostics Lab., Department of Biochemistry, Faculty of Science, The Maharaja Sayajirao University of Baroda, Sayajigunj,…. Hauptthemen laut MEDLINE: Huntingtin Protein, Huntington Disease. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Indian Council of Medical Research, DST-SERB, Government of India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Huntington’s disease (HD) is a fatal neurodegenerative disease caused by CAG trinucleotide repeat expansion in the huntingtin gene (Htt) resulting in an expanded polyglutamine (polyQ) tract in the huntingtin (HTT) protein. The expanded polyQ alters structure of HTT making it susceptible to aggregation. The expression of mutant HTT (mHTT) causes dysregulation of several key cellular pathways in neuronal cells resulting in neurodegeneration. Recent studies have demonstrated phosphorylation of the N-terminal domain of the huntingtin (N-HTT) protein as an important regulator of its localization, structure, aggregation, clearance and toxicity. Most studies have focused on the effect of phosphorylation of Ser13 and Ser16 in N-HTT on protein aggregation and reported a drastic reduction in aggregation. However, the downstream impact of this phosphorylation status on key cellular pathways is largely unexplored. Utilizing an inducible cell line model for expression of Exon 1 fragment of mHTT bearing 150 polyglutamine repeats (HD150Q), we demonstrate that kinetin induced phosphorylation at Ser13 and Ser16 of N-HTT resulted in prevention of aggregation as well as resolution of preformed aggregates. Furthermore, kinetin treatment led to rescue of ATP levels and transcription of key genes as well as significant reduction in mitochondrial ROS levels restoring mitochondrial function. Notably, ER stress markers were significantly reduced at transcriptional, translational and post-translational levels. Restoration of mitochondrial function and mitigation of ER stress lead to significant improvement in cell survival. These findings further strengthen the view that HTT N-terminal phosphorylation is a promising therapeutic target for HD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Huntingtin ProteinHuntington DiseasePhosphorylationHumansCell LineTrinucleotide Repeat ExpansionPeptidesMutationNeuronsMitochondria

Stichwörter der Autor:innen

Huntingtin phosphorylationHuntington’s diseaseKinetinMutant huntingtin

Substanzen

Huntingtin ProteinHTT protein, humanpolyglutaminePeptides

Autor:innen und Institutionen

  • Neurobiology and Molecular Diagnostics Lab., Department of Biochemistry, Faculty of Science, The Maharaja Sayajirao University of Baroda, Sayajigunj, Vadodara, Gujarat 390002, India.

Förderung

  • Indian Council of Medical Research
  • DST-SERB, Government of India

Zitieren

APA

Dabhi, R., Mehta, R., Kakadiya, D., & Vijayvargia, R. (2025). Kinetin mediated mutant huntingtin phosphorylation restores multiple dysregulated pathways in a cell line model of Huntington’s disease. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddaf052

Vancouver

Dabhi R, Mehta R, Kakadiya D, Vijayvargia R. Kinetin mediated mutant huntingtin phosphorylation restores multiple dysregulated pathways in a cell line model of Huntington’s disease. Human Molecular Genetics. 2025. doi:10.1093/hmg/ddaf052

BibTeX
@article{Dabhi2025,
  author = {Dabhi, Rajubhai and Mehta, Ragi and Kakadiya, Dhruvi and Vijayvargia, Ravi},
  title = {Kinetin mediated mutant huntingtin phosphorylation restores multiple dysregulated pathways in a cell line model of Huntington’s disease},
  journal = {Human Molecular Genetics},
  year = {2025},
  doi = {10.1093/hmg/ddaf052}
}
Kostenlos starten →